Skip to main content
Clinical Trials/CTRI/2014/07/004756
CTRI/2014/07/004756
Completed
Phase 2

A clinical study to evaluate efficacy and safety of Appetol syrup in children suffering from non-specific anorexia - NI

ARJUN HEALTHCARE0 sites50 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ARJUN HEALTHCARE
Enrollment
50
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1 The informed consent document must be read signed and dated by subjects legally authorized representative before conducting any study procedures or examination
  • 2 Males and females between 5 to 9 years of age
  • 3\.Subjects suffering from non specific anorexia
  • 4\.Subjects having normal vital parameters

Exclusion Criteria

  • 1 Children with SNAQ score less than or equal to 14
  • 2 Children with chronic illnesses congenital abnormalities
  • 3 Subject who is on other appetite stimulants sedatives narcotics and steroidal drugs
  • 4 Subjects who have received treatment another investigational agent within last thirty days from Screening Visit
  • 5 Subjects who have received chemotherapy or radiation therapy within the past 5 years
  • 6 Subjects on systemic antibiotics or systemic therapy with cytotoxic drugs
  • 7 Subjects having metabolic and or endocrine disorders
  • 8 Subjects with any type of GI tract disorder including malabsorption syndrome etc
  • 9 Subjects with liver and renal disorders
  • 10 Subjects with known immunological, hematologic disorders or malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials